Search research articles
Contact Us
Filters
Showing results (151-160 of 219) with videos related to
Page
of 22
Sort By:
JCO Precision Oncology
|
October 7, 2024
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program
Antonio Vitale, Luca Mastrantoni, Jacopo Russo, et al.
Frontiers in Medicine
|
October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry
Antonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Rheumatology (Oxford, England)
|
May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry
Jurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
Carla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine
|
January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Frontiers in Medicine
|
July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
Antonio Vitale, Laura Obici, Marco Cattalini, et al.
Frontiers in Medicine
|
June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Frontiers in Pharmacology
|
September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
Jurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Ophthalmology and Therapy
|
April 2, 2024
Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA Network
Carla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, et al.
Rheumatology (Oxford, England)
|
January 25, 2022
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease
Piero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 219) with videos related to
Sort By:
Page
of 22
JCO Precision Oncology
|
October 7, 2024
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program
Antonio Vitale, Luca Mastrantoni, Jacopo Russo, et al.
Frontiers in Medicine
|
October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry
Antonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Rheumatology (Oxford, England)
|
May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry
Jurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease
|
September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
Carla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine
|
January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Frontiers in Medicine
|
July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
Antonio Vitale, Laura Obici, Marco Cattalini, et al.
Frontiers in Medicine
|
June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Frontiers in Pharmacology
|
September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
Jurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Ophthalmology and Therapy
|
April 2, 2024
Ocular Manifestations in Juvenile Behçet's Disease: A Registry-Based Analysis from the AIDA Network
Carla Gaggiano, Abdurrahman Tufan, Silvana Guerriero, et al.
Rheumatology (Oxford, England)
|
January 25, 2022
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease
Piero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Page
of 22